glutathione rapta c The development of anticancer ruthenium(II) complexes: from single molecule compounds to nanomaterials Combinative Treatment of the PARP
Combinative Treatment of the PARP Inhibitor Olaparib and Antimetastasis Ruthenium(II)Arene Compound RAPTA T for Triple Negative BRCA1 Wild Type Breast Cancer Cells Structural variations of the ligands in the lead compound RAPTA C. Download Scientific Diagram State of Metal Based Drugs for the Efficient Therapy of Lung Cancers and Lung Metastases Oncohema Key Anticancer activity of RAPTA EA1 in triple negative BRCA1 proficient breast cancer cells: single and combined treatment with the PARP inhibitor olaparib ScienceDirect The development of RAPTA compounds for the treatment of tumors ScienceDirect
Pay in 4 interest-free payments of $7.36 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 15 - Sep 20




